BI 655066
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BI 655066, covering 2016-09-19 to 2019-07-15. Get the full timeline:
Most recent: Clinical Trial Update: BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]